PN

Pui Yee Ng

FT Forma Therapeutics: 35 patents #5 of 86Top 6%
VH Valo Health: 16 patents #2 of 53Top 4%
SP Sirtris Pharmaceuticals: 11 patents #2 of 20Top 10%
VD Valo Early Discovery: 10 patents #2 of 30Top 7%
GL Glaxosmithkline: 6 patents #32 of 646Top 5%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
Overall (All Time): #23,501 of 4,157,543Top 1%
78
Patents All Time

Issued Patents All Time

Showing 25 most recent of 78 patents

Patent #TitleCo-InventorsDate
12304904 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Aleksandra Rudnitskaya, David R. Lancia, Jr. 2025-05-20
12264137 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2025-04-01
12213969 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Xiaozhang Zheng, Mary-Margaret Zablocki 2025-02-04
12162888 Carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Zhongguo Wang, Tatiana Shelekhin, Justin Andrew Caravella, Mary-Margaret Zablocki +3 more 2024-12-10
11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2024-03-05
11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2024-02-06
11730721 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Xiaozhang Zheng, Mary-Margaret Zablocki 2023-08-22
11702412 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Aleksandra Rudnitskaya, David R. Lancia, Jr. 2023-07-18
11535607 Isoindolines as HDAC inhibitors Xiaozhang Zheng, Matthew W. Martin, Jennifer R. Thomason, Bingsong Han, Aleksandra Rudnitskaya +1 more 2022-12-27
11524966 Carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Zhongguo Wang, Tatiana Shelekhin, Justin Andrew Caravella, Hongbin Li +2 more 2022-12-13
11414392 [6,6] fused bicyclic HDAC8 inhibitors Xiaozhang Zheng, Jennifer R. Thomason, Mary-Margaret Zablocki, Bingsong Han, Nicholas Barczak +4 more 2022-08-16
11345672 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more 2022-05-31
11325917 Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2022-05-10
11279681 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2022-03-22
11274084 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2022-03-15
11274085 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2022-03-15
10988450 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2021-04-27
10988441 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2021-04-27
10913753 Thienopyridine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-02-09
10889592 Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-01-12
10874649 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Xiaozhang Zheng, Mary-Margaret Zablocki 2020-12-29
10870645 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Aleksandra Rudnitskaya, David R. Lancia, Jr. 2020-12-22
10829462 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2020-11-10
10829461 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2020-11-10
10829460 [6,6] fused bicyclic HDAC8 inhibitors Xiaozhang Zheng, Jennifer R. Thomason, Mary-Margaret Zablocki, Bingsong Han, Nicholas Barczak +4 more 2020-11-10